Strategies to prevent anaemia in preterm newborns include drawing fewer blood samples, the use of recombinant human erythropoietin and iron supplementation. Although iron sulphate is the most commonly used pharmaceutical formulation for iron supplementation, there are few studies comparing different iron salts in newborns.
Iron supplementation with iron sulfate versus iron bisglycinate chelate in preterm infants
Boetti, Tatiana;Cester, Elena Andrea;Bertino, Enrico;Coscia, Alessandra
2018-01-01
Abstract
Strategies to prevent anaemia in preterm newborns include drawing fewer blood samples, the use of recombinant human erythropoietin and iron supplementation. Although iron sulphate is the most commonly used pharmaceutical formulation for iron supplementation, there are few studies comparing different iron salts in newborns.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2nd Bagna MS.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
784.14 kB
Formato
Adobe PDF
|
784.14 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
